ArticlemedRxiv : the preprint server for health sciences2026
LitBench: A Benchmark for Retrieval-Grounded Multi-Paper Evidence Synthesis in Epilepsy.
Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Background: Clinicians increasingly use AI systems to search Methods: LitBench comprises 1,980 open-access papers (1,000 epilepsy papers holding the answers, 980 decoys from unrelated fields) and 9,472 human-reviewed facts, giving 2,188 single-paper questions and 170 requiring a fact from each of two papers. Difficulty rose by burying the answer among up to 2,000 distractors, then again over live PubMed Central. The same questions were then asked with the answering paper removed, so that refusal was the correct response. Four systems were tested: Gemma-4B, Gemma-12B, Sonnet-5, and DeepSeek-V4-Flash (refusal conditions only). Three model judges scored each answer by majority; two-paper questions counted only when both facts were found. Results: Across fixed-corpus single-paper conditions, accuracy ranged from 55.9% to 71.9% for Gemma-4B, 61.2% to 75.5% for Gemma-12B, and 90.0% to 91.3% for Sonnet-5. Similar epilepsy papers were harder than mixed candidate sets for both Gemma configurations. Two-paper accuracy was 5.7%, 17.1%, and 37.8%, respectively. With evidence absent, Gemma-12B refusal fell from 88.3% to 39.9% as candidate sets grew; Gemma-4B almost never refused. Sonnet-5 refused on 94.9% of sampled single-paper and all sampled two-paper cells. DeepSeek-V4-Flash also refused frequently, but on 80.3% of matched answer-present controls. Conclusions: No system was reliable across every axis tested: accuracy fell as competing papers were added, interpretation-requiring facts were harder than stated ones, two-paper synthesis was rarely achieved, and only some systems recognized absent evidence. What counts as "successful" literature search carries considerable nuance; LitBench can evaluate proposed tools ata fine-grained level.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.